Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Tougher tactics for the unvaccinated needed for rise in COVID-19?

With coronavirus cases rising among the unvaccinated and…
Read more

North Carolina GOP Seeks Ban on Critical Race ‘Indoctrination’

GOP Senate leader Phil Berger said his chamber is taking…
Read more

Amazon Considered Developing Alexa Tracking Device for Children

Amazon.com Inc., whose home and surveillance devices have…
Read more